Navigation Links
Daiichi Sankyo CEO John Gargiulo Elected as National Pharmaceutical Council's Chairman of the Board
Date:11/2/2012

WASHINGTON, Nov. 2, 2012 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that John Gargiulo, President & CEO, Daiichi Sankyo, Inc., has been elected Chairman of its Board of Directors for 2012-13. Mr. Gargiulo has served on NPC's Board since 2007, most recently as Vice Chair.

(Photo: http://photos.prnewswire.com/prnh/20121102/DC05271)

"For many years, John has been committed to fostering NPC's growth as a leading health care policy research organization," said NPC President Dan Leonard. "We're looking forward to his leadership as chairman.  He brings a strong track record of accomplishment from Daiichi Sankyo and a keen understanding of the issues facing our industry and actionable ideas for change."

"Now more than ever, we need to demonstrate that pharmaceuticals not only successfully treat and cure disease, but that they can help manage the costs of health care over time.  By managing chronic and preventable diseases with medicines that have proven to work, we can reduce hospitalizations, and most of all, help people lead longer and healthier lives," said Mr. Gargiulo. "As chairman, I'm looking forward to leading NPC as it continues to move forward on issues related to balancing the needs of patients with the population, the value of pharmaceuticals, and the use of real-world evidence."

Mr. Gargiulo has more than 25 years of pharmaceutical industry experience. He has been instrumental in building and shaping the company's U.S. commercial operations, particularly its cardiovascular business, since its inception in 1996. He has touched nearly every aspect of business operations including Marketing, Managed Markets and New Product Planning. In the U.S. Daiichi Sankyo markets therapies in hypertension, dyslipidemia, diabetes, acute coronary syndrome and metastatic melanoma.

The NPC Board also elected Jeff Huth, Senior Vice President, Managed Markets, Boehringer Ingelheim Pharmaceuticals, Inc., to serve as its Vice Chair, and Anne Whitaker, President, North America Pharmaceuticals, Sanofi, as Treasurer. Rich Fante, President, U.S. Business & Regional Vice President, Americas, AstraZeneca, is the outgoing chair and will remain active on NPC's Board.

"Under Rich's leadership,  NPC took a leap forward as an organization, becoming a more powerful voice in educating key health care stakeholders about the development and application of comparative effectiveness research and other data important to improving health outcomes," said Mr. Leonard.

About the National Pharmaceutical Council
The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.  


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Daiichi Sankyo ha completato larruolamento dei pazienti per lo studio Hokusai-VTE su Edoxaban, il più ampio trial clinico di fase 3 per il trattamento delle tromboembolie venose ricorrenti
2. Daiichi Sankyo Completes Enrolment in Hokusai - VTE, investigating once-daily Edoxaban in the Largest Single Phase 3 Study for the Treatment and Prevention of Recurrence of VTE
3. Daiichi Sankyo, Inc. Receives FDA Approval to Package Product at New Facility in Bethlehem, PA
4. Varian Medical Systems Selected by Leading Russian Development Foundations to Take Part in High-Profile Supplier Event
5. DebMed Selected By Three Leading Healthcare Group Purchasing Organizations To Demonstrate Innovative Patient Safety Solution
6. Mylan Selected as a Leading ARV Supplier to Indias National AIDS Control Organization
7. NIH Director Francis S. Collins, M.D., Ph.D. Selected as 2012 Pro Bono Humanum Honoree by Prix Galien USA
8. Pharmaceutical Industry Veteran Al Altomari Elected To Insmeds Board Of Directors
9. Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors
10. ApolloMed ACO Selected To Participate In A Transformative New Initiative Sponsored by the Centers for Medicare and Medicaid Services
11. Nature Made Selected As "Top Recommended Health Product" By U.S. News & World Report And Pharmacy Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , Dec. 7, 2016   Arena Pharmaceuticals, Inc. ... it has completed enrollment in the ralinepag phase 2 ... targeting the prostacyclin pathway for the treatment of pulmonary ... at sites globally. "This marks an important ... of our strategic focus on our pipeline," said ...
(Date:12/7/2016)... Diplomat Pharmacy, Inc. (NYSE: DPLO) has launched Diplomat Specialty Infusion Group, ... Professional, BioRx, MedPro Rx, and XAS Infusion Suites. To ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ... we continue to build on the work we have done, we ...
(Date:12/7/2016)... 2016   Rx Savings Solutions has partnered with ... its Public Employees Insurance Agency (PEIA) to offer more than ... healthcare software, ultimately saving money on their prescriptions. ... members with access to our software that will alert them ... therapy can be found," says Michael Rea , founder ...
Breaking Medicine Technology:
(Date:12/7/2016)... CT (PRWEB) , ... December 07, 2016 , ... A ... prompted an outpouring of comments on social media that offer a rare glimpse into ... psychiatrist, leading ADHD authority and New York Times bestselling author, has described people with ...
(Date:12/7/2016)... MA (PRWEB) , ... December 07, 2016 , ... They ... They are sisters and wives, brothers and fathers, from New England and around the ... and its stigma, and are brought together in a beautiful and compelling new photographic ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... performance connectors, is now promoting to the US market its advanced highly customizable ... LAMTAC® and ODU TURNTAC®. These advanced technologies are ideal for a wide ...
(Date:12/7/2016)... ... December 07, 2016 , ... Baciocco ... services to residents in the Sacramento/Folsom region, is initiating a charity event to ... The Another Choice Another Chance treatment center in Sacramento works to provide area ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... One ... regular changing of the securement tape is painful for her. "This is why the ... to patients’ heads," she said. , They then created a prototype of the patent-pending ...
Breaking Medicine News(10 mins):